| (1) |
Vanderpump MPJ, Tunbridge WMG. The epide-miology of thyroid diseases.
In: Braverman LE, Utiger RD, eds. Werner and Ingbarﾕs The Thyroid: A Fundamental
and Clinical Text. 7th ed. Philadelphia, Pa: Lippincott-Raven; 1996. |
| (2) |
Tunbridge WM, Evered DC, Hall R, et al. The spectrum
of thyroid disease in a community: the Whickham Survey. Clin Endocrinol
(Oxf). 1977; 7: 481-493. |
| (3) |
Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid
disorders in the community: a twenty-year follow-up of the Whickham Sur-vey.
Clin Endocrinol (Oxf). 1995; 43: 55-68. |
| (4) |
Sawin CT, Castelli WP, Hershman JM, McNa-mara P, Bacharach P. The aging
thyroid: thyroiddeficiency in the Framingham Study. Arch Intern Med. 1985;
145: 1386-1388. |
| (5) |
Bagchi N, Brown TR, Parish RF. Thyroid dysfunction in adults over age
55 years: a study in an urban US community. Arch Intern Med. 1990; 150:
785-787. |
| (6) |
Singer PA, Cooper DS, Levy EG, et al. Treatment guidelines for patients
with hyperthyroidism and hypothyroidism. JAMA. 1995; 273: 808-812. |
| (7) |
Klee GG, Hay ID. Biochemical testing of thyroid function. Endocrinol Metab
Clin North Am. 1997; 26: 763-775. |
| (8) |
Rosenthal MJ, Hunt WC, Garry PJ, Goodwin JS. Thyroid failure in the elderly:
microsomal antibodies as discriminant for therapy. JAMA. 1987; 258: 209-213. |
| (9) |
Tanis BC, Westendorp GJ, Smelt HM. Effect of thyroid substitution on hypercholesterolaemia
in patients with subclinical hypothyroidism: a reanaly-sis of intervention
studies. Clin Endocrinol (Oxf).1996; 44: 643-649. |
| (10) |
Arem R, Patsch W. Lipoprotein and apolipoprotein levels in subclinical
hypothyroidism: effect of levothyroxine therapy. Arch Intern Med. 1990;
150: 2097-2100. |
| (11) |
Staub JJ, Althaus BU, Engler H, et al. Spectrum of subclinical and overt
hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and
metabolic impact on peripheral target tissues. Am J Med. 1992; 92: 631-642. |
| (12) |
Franklyn JA, Daykin J, Betteridge J, et al. Thyroxine replacement therapy
and circulating lipid concentrations. Clin Endocrinol (Oxf). 1993; 38: 453-459. |
| (13) |
Cooper DS, Halpern R, Wood LC, Levin AA, Ridg-way EC. L-Thyroxine therapy
in subclinical hypo-thyroidism: a double-blind, placebo-controlled trial.
Ann Intern Med. 1984; 101: 18-24. |
| (14) |
Nystrom E, Caidahl K, Fager G, Wikkelso C, Lundberg PA, Lindstedt G. A
double-blind crossover 12-month study of L-thyroxine treatment of women
with tsubclinicalﾓ hypothyroidism. Clin Endocrinol (Oxf). 1988; 29: 63-76. |
| (15) |
Jaeschke R, Guyatt G, Gerstein H, et al. Does treatment with L-thyroxine
influence health status in middle-aged and older adults with subclinical
hypothyroidism? J Gen Intern Med. 1996; 11: 744-749. |
| (16) |
Baldini IM, Vita A, Mauri MC, et al. Psychopathological and cognitive
features in subclinical hypothyroidism. Prog Neuropsychopharmacol Biol Psychiatry.
1997; 21: 925-935. |
| (17) |
Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations
as a risk factor for atrial fibrillation in older persons. N Engl J Med.
1994; 331: 1249-1252. |
| (18) |
Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY. Effects
on bone mass of long term treatment with thyroid hormones: a meta-analysis.
J Clin Endocrinol Metab. 1996; 81: 4278-4289. |
| (19) |
Faber J, Galloe AM. Changes in bone mass during prolonged subclinical
hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol.
1994; 130: 350-356. |
| (20) |
Biondi B, Fazio S, Carella C, et al. Control of adrenergic overactivity
by beta-blockade improves the quality of life in patients receiving long
term suppressive therapy with levothyroxine. J Clin Endocrinol Metab. 1994;
78: 1028-1033. |
| (21) |
Spencer CA, Takeuchi M, Kazarosyan M. Current status and performance goals
for serum thyrotropin (TSH) assays. Clin Chem. 1996; 42: 140-145. |
| (22) |
Danese MD, Powe NR, Sawin CT, Ladenson PW. Screening for mild thyroid
failure at the periodic health examination: a decision and cost-effectiveness
analysis. JAMA. 1996; 276: 285-292. |
| (23) |
Guide to Clinical Preventive Services: Report of the U.S. Preventive Services
Task Force. 2nd ed.
Baltimore, Md: Williams & Wilkins; 1995. |